Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

BioNxt Solutions Inc C.BNXT

Alternate Symbol(s):  BNXTF

BioNxt Solutions Inc. is a bioscience company. The Company is focused on drug formulations and delivery systems, diagnostic screening tests, and new active pharmaceutical ingredient investment opportunities, including precision transdermal and oral dissolvable drug formulations; rapid, low-cost infectious disease and oral health screening tests; and standardization of emerging active pharmaceutical ingredients for neurological applications. The Company has research and development operations in North America and Europe, with an operational focus in Germany. The Company is also focused on regulatory approval and commercialization of medical products for European markets. Its diagnostic products include COVID-19 PCR Diagnostic Kit, Peri-Implantitis Oral Biosensor, and H1N1 (Swine Flu) and H5N1 (Avian Flu) Oral Biosensors. Its subsidiaries include XPhyto Laboratories Inc., Bunker Pflanzenextrakte GmbH, Vektor Pharma TF GmbH, BioNxt Europe GmbH, and 3a-diagnostics GmbH, among others.


CSE:BNXT - Post by User

Post by wallpaper2on Nov 29, 2020 11:53am
855 Views
Post# 31996729

A sleeper in North America but not for long.

A sleeper in North America but not for long.A solid following in Germany and parts of Europe. They have a leading team, a steady cash flow and a continual line of new products coming to market. They have a marketing aliance and key 
partnerships in place while retaining 100% proprietary intelligence.  They have been working on Saliva based test kits for many months as well as the gold standard PCR test.  They now have the ability to turn days of waiting for results into minutes. They have found a way of placing these advances into every DR.s office or any location you wish for approx. $20 a pop ! This will go world wide in Q! 2021....that isn't far away folks.  A news announcement is expected early this COMING WEEK  which will apparently answer all your questions.   "Market Herald Canada"  published a second great article 3 days ago outling XPHYTO's company.  You should give it a read while you can afford it.  
<< Previous
Bullboard Posts
Next >>